Page last updated: 2024-10-25

clofibrate and Ataxia

clofibrate has been researched along with Ataxia in 1 studies

angiokapsul: contains clofibrate & insoitolnicotinate

Ataxia: Impairment of the ability to perform smoothly coordinated voluntary movements. This condition may affect the limbs, trunk, eyes, pharynx, larynx, and other structures. Ataxia may result from impaired sensory or motor function. Sensory ataxia may result from posterior column injury or PERIPHERAL NERVE DISEASES. Motor ataxia may be associated with CEREBELLAR DISEASES; CEREBRAL CORTEX diseases; THALAMIC DISEASES; BASAL GANGLIA DISEASES; injury to the RED NUCLEUS; and other conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Oyagbemi, AA1
Adebiyi, OE1
Adigun, KO1
Ogunpolu, BS1
Falayi, OO1
Hassan, FO1
Folarin, OR1
Adebayo, AK1
Adejumobi, OA1
Asenuga, ER1
Ola-Davies, OE1
Omobowale, TO1
Olopade, JO1
Saba, AB1
Adedapo, AA1
Nkadimeng, SM1
McGaw, LJ1
Oguntibeju, OO1
Yakubu, MA1

Other Studies

1 other study available for clofibrate and Ataxia

ArticleYear
Clofibrate, a PPAR-α agonist, abrogates sodium fluoride-induced neuroinflammation, oxidative stress, and motor incoordination via modulation of GFAP/Iba-1/anti-calbindin signaling pathways.
    Environmental toxicology, 2020, Volume: 35, Issue:2

    Topics: Animals; Ataxia; Biomarkers; Calbindins; Calcium-Binding Proteins; Clofibrate; Fluorides; Glial Fibr

2020